Le Bonheur and University of Tennessee Health Science Center Physicians Lead Research During COVID-19

Several physicians and researchers from Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center (UTHSC) have been recognized in Research News Quarterly from the American Thoracic Society (ATS) for thought leadership during the current coronavirus pandemic. This “COVID Collection” was coordinated by Le Bonheur Researcher Amali Samarasinghe, PhD.

  • As the virus hit cities unique in population demographics, health disparities and socioeconomic status, countermeasures and health care strategies needed to be formulated to fit various cities’ needs. Pediatrician-in-Chief and pandemic expert Jon McCullers, MD, and Vice President of Clinical Affairs Terri Finkel, MD, PhD, describe Memphis’ response to the first wave of SARS-CoV-2, including testing strategies, public health advocacy and additional research.


  • Patricia Dubin, MD, a member of the ATS Pediatrics Assembly, and Infectious Disease expert Nicholas Hysmith, MD, discuss the impact of this pandemic on clinical research, balancing trainee research requirements and the risks of not engaging in research with increased exposure and diminished PPE supply when labs are re-opened.


  • Amali E. Samarasinghe, PhD, addresses the importance of understanding patients with chronic lung disease to determine possible ways COVID-19 may impact them now and in the future.


You can read these research studies in their entirety by visiting Thoracic.org.


About Le Bonheur Children’s:

Le Bonheur Children’s Hospital in Memphis, Tenn., treats children through community programs, regional clinics and a 255-bed state-of-the-art hospital. Le Bonheur serves as a primary teaching affiliate for the University Tennessee Health Science Center and trains more than 350 pediatricians and specialists each year. Nationally recognized, Le Bonheur is ranked by U.S. News & World Report as a Best Children’s Hospital. 

For more information, please call (901) 287-6030 or visit lebonheur.org. Connect with us at facebook.com/lebonheurchildrens, twitter.com/lebonheurchild or on Instagram at lebonheurchildrens.


About University of Tennessee Health Science Center:

 As Tennessee’s only public, statewide, academic health system, the mission of the University of Tennessee Health Science Center is to bring the benefits of the health sciences to the achievement and maintenance of human health through education, research, clinical care, and public service, with a focus on the citizens of Tennessee and the region. The main campus in Memphis includes six colleges: Dentistry, Graduate Health Sciences, Health Professions, Medicine, Nursing and Pharmacy. UTHSC also educates and trains medicine, pharmacy, and/or health professions students, as well as medical residents and fellows, at major sites in Knoxville, Chattanooga and Nashville. For more information, visit www.uthsc.edu. Find us on Facebook: facebook.com/uthsc, on Twitter: twitter.com/uthsc and on Instagram: instagram.com/uthsc.

Posted: 6/26/20

Related News

Fighting Obesity Family Style with MEALS
Posted: 10/22/20
Thomaseo Burton, PhD, and Webb Smith, PhD, of Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center have developed a novel intervention in the home kitchen to address obesity.
Neural Crest Cell Migration in Hirschsprung Disease Research
Posted: 10/13/20
Ankush Gosain, MD, PhD, of Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center has focused his research on determining the mechanisms underlying abnormal development of the enteric nervous system in Hirschsprung disease. Gosain recently published a new study in The FASEB Journal.
Influenza A virus directly modulates eosinophil responses
Posted: 8/5/20
Eosinophils residing in the airways of mice respond to influenza A virus (IAV) infection through alterations in surface expression of various markers necessary for migration and cellular immunity responses, according to research published in the Journal of Leukocyte Biology by researchers from Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center.
Le Bonheur Children’s Hospital Trial: Intravenous Indomethacin
Posted: 7/22/20
Le Bonheur and the University of Tennessee Health Science Center neonatologists, led by Jennifer M. Davidson, DO, conducted a randomized trial for the treatment of hemodynamically significant PDAs (hsPDAs) in very low birth weight (VLBW) infants. Echocardiogram criteria before and after treatment showed that IV indomethacin was more effective.